(A) Health related benefits to vaccinated individuals
|
(1) Mortality |
Health benefits achieved by reducing number of deaths. |
(2) Morbidity |
Health benefits achieved by reducing morbidity and improving quality of life. |
(3) Healthcare expenditure |
Reduction in medical expenditures for healthcare system. |
|
(B) Short-term and long-term productivity gains
|
(4) School absenteeism |
Reduction in amount of schooldays missed due to illness. |
(5) Care-related productivity |
Increased individual productivity due to reduction in lost working days. |
(6) Outcome-related productivity |
Increased individual lifetime productivity and participation due to improved health. |
|
(C) Community or health systems externalities
|
(7) Impact on other diseases |
Impact on incidence numbers of closely related diseases not vaccinated for. |
(8) Community health externalities |
Externalities among the unvaccinated community members. |
(9) Outbreak prevention costs |
Impact on disease outbreak investigations and prevention. |
(10) Equity |
Impact on equity issues in the society. |
(11) Risk reduction |
Impact on welfare of households due to reduced uncertainty in future outcomes and health expenditures. |
(12) Economies of scale |
Impact on per dose price of vaccine due to changes in demand. |
|
(D) Broader economic indicators
|
(13) Behaviour-related productivity |
Economic benefits for families as a result of improved child health and survival. |
(14) Demographic dividend |
Economic effects of changes in demographic composition of society. |
(15) Employment in society |
Impact on overall employment in society. |
(16) Impact on consumption behaviour |
Impact on the consumption of the general population. |
(17) Impact on gross domestic product (GDP) |
Impact on gross domestic product in general. |
(18) Impact on tax revenue |
Impact on tax revenues. |